RESEARCH IN ENGLAND
Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.
159 matching studies · ordered by study identifier.
The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.
NCT05533697 · Interventional
Advanced Solid Tumors
Study overall: Recruiting · source record updated 14 July 2026.
8 England locations · 8 explicitly recorded as recruiting.
NCT05539040 · Interventional
Cardiac Arrhythmia · Atrial Fibrillation
Study overall: Recruiting · source record updated 28 September 2023.
1 England locations · 1 explicitly recorded as recruiting.
NCT05552222 · Interventional
Multiple Myeloma
Study overall: Recruiting · source record updated 28 August 2026.
8 England locations · 8 explicitly recorded as recruiting.
NCT05574647 · Interventional
Prostate Cancer · Adenocarcinoma · Prostatic Neoplasms · Prostatic Diseases · Neoplasms
Study overall: Recruiting · source record updated 24 July 2025.
15 England locations · 14 explicitly recorded as recruiting.
NCT05624450 · Interventional
Viral Lung Infection and Acute Respiratory Failure
Study overall: Recruiting · source record updated 28 August 2026.
12 England locations · 10 explicitly recorded as recruiting.
NCT05629702 · Interventional
Glioblastoma · Brain Tumor · Cannabis · Brain Tumor, Recurrent
Study overall: Recruiting · source record updated 5 May 2026.
16 England locations · 14 explicitly recorded as recruiting.
NCT05730036 · Interventional
Relapsed Refractory Multiple Myeloma (RRMM)
Study overall: Recruiting · source record updated 6 March 2026.
7 England locations · 0 explicitly recorded as recruiting.
NCT05735639 · Interventional
Venous Thromboembolism · Varicose Veins
Study overall: Recruiting · source record updated 4 June 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT05786924 · Interventional
Non-small Cell Lung Cancer · Histiocytic Neoplasm · Histiocytosis · BRAF Gene Mutation · BRAF V600E · BRAF V600 Mutation · BRAF Mutation-Related Tumors · BRAF · Metastatic Lung Non-Small Cell Carcinoma · Metastatic Lung Cancer · Recurrent Lung Cancer · Recurrent Lung Non-Small Cell Carcinoma · NSCLC · Solid Tumor · Solid Carcinoma · KRAS G12D · KRAS G12V · KRAS Mutation-Related Tumors · NRAS Gene Mutation · Thyroid Cancer · Thyroid Carcinoma · Colorectal Cancer · Colorectal Carcinoma · Recurrent Histiocytic and Dendritic Cell Neoplasm · Brain Metastases · Recurrent NSCLC · KRAS G13C · Acquired Resistance to KRAS G12C Inhibitor · KRAS G12A · KRAS G12F · KRAS G12R · KRAS G13D
Study overall: Recruiting · source record updated 17 June 2026.
3 England locations · 3 explicitly recorded as recruiting.
NCT05836324 · Interventional
Solid Tumors · Advanced Solid Tumors · Metastatic Solid Tumors
Study overall: Recruiting · source record updated 23 July 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT05841199 · Observational
Ventricular Tachycardia · Coronary Artery Disease · Heart Failure · Coronary Microvascular Dysfunction · Coronary Microvascular Disease
Study overall: Recruiting · source record updated 27 March 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT05885295 · Observational
Stroke · Stroke (CVA) or TIA · Dementia, Vascular · Cerebrovascular Disorders · Small Vessel Cerebrovascular Disease · Cognitive Impairment
Study overall: Recruiting · source record updated 1 June 2023.
1 England locations · 1 explicitly recorded as recruiting.
NCT06026345 · Observational
Atrial Fibrillation
Study overall: Recruiting · source record updated 7 October 2025.
2 England locations · 2 explicitly recorded as recruiting.
NCT06056297 · Interventional
Neutropenia
Study overall: Recruiting · source record updated 6 August 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT06064461 · Observational
Myasthenia Gravis
Study overall: Recruiting · source record updated 29 July 2025.
2 England locations · 2 explicitly recorded as recruiting.
NCT06093672 · Interventional
Polycythemia Vera
Study overall: Recruiting · source record updated 25 March 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT06136624 · Interventional
Prostate Cancer Metastatic
Study overall: Recruiting · source record updated 3 September 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT06136650 · Interventional
Metastatic Castration-resistant Prostate Cancer (mCRPC) · Prostatic Neoplasms
Study overall: Recruiting · source record updated 24 August 2026.
12 England locations · 11 explicitly recorded as recruiting.
NCT06163430 · Interventional
Chronic Myeloid Leukemia, Chronic Phase · Chronic Myeloid Leukemia
Study overall: Recruiting · source record updated 12 January 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT06169163 · Observational
Oesophageal Squamous Cell Carcinoma · Oesophageal Cancer
Study overall: Recruiting · source record updated 2 May 2025.
10 England locations · 7 explicitly recorded as recruiting.
This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.